Advertisement
UK markets close in 7 hours 8 minutes
  • FTSE 100

    7,957.04
    +25.06 (+0.32%)
     
  • FTSE 250

    19,792.96
    -17.70 (-0.09%)
     
  • AIM

    741.60
    -0.51 (-0.07%)
     
  • GBP/EUR

    1.1678
    +0.0009 (+0.08%)
     
  • GBP/USD

    1.2589
    -0.0049 (-0.39%)
     
  • Bitcoin GBP

    56,184.01
    +754.48 (+1.36%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,248.49
    +44.91 (+0.86%)
     
  • DOW

    39,760.08
    +477.75 (+1.22%)
     
  • CRUDE OIL

    81.58
    +0.23 (+0.28%)
     
  • GOLD FUTURES

    2,214.20
    +1.50 (+0.07%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • HANG SENG

    16,541.42
    +148.58 (+0.91%)
     
  • DAX

    18,500.75
    +23.66 (+0.13%)
     
  • CAC 40

    8,239.44
    +34.63 (+0.42%)
     

Sunday share tips: London Stock Exchange, International Personal Finance, Microsaic

LONDON (ShareCast) - Buy shares of London Stock Exchange (Other OTC: LDNXF - news) (LSE), Danny Fortson recommended in the Sunday Times. The Inside the City columnist said since chief executive Xavier Rolet took over in 2009 LSE it has outperformed the FTSE 100 threefold. Rolet has transformed LSE through 16 acquisitions and only about a quarter of profits come from managing the London stock market. A bid premium could creep back into the shares and the planned sale of the Russell fund management business could bring in £1bn. Rolet has plenty of levers to pull. Hold shares of International Personal Finance (LSE: IPF.L - news) (IPF), Questor advised in the Sunday Telegraph. The former overseas arm of Provident Financial (Other OTC: FPLPF - news) , which sells loans to borrowers denied credit elsewhere, has been an unloved stock. It operates in Hungary, Poland and other central European countries plus Mexico and Spain and faces regulatory crackdowns in some markets. Supportive analysts have said IPF's internet platform is taking off and that investment in Spain and online is masking better performance. IPF trades at 11 times earnings compared with 14 times for its former parent Provident.

Shares (Berlin: DI6.BE - news) of AIM-listed Microsaic Systems (LSE: MSYS.L - news) are worth a punt for adventurous investors, Midas (SES: E1:5EN.SI - news) said in the Mail on Sunday. The company has developed a smaller version of a mass spectrometer, which analyses substances such as early-stage drugs and drinking water. Microsaic's products cost a third of the £100,000 price of a traditional mass spectrometer, are easily transported and need less specialist knowledge to operate. It has signed several contracts, including to supply GE Healthcare in the US. With other opportunities in the pipeline and the backing of top investors such as BlackRock (NYSE: BLK - news) , the shares are not for the cautious but should increase substantially.

Existing shareholders of Primary Health Properties (LSE: PHP.L - news) should stick with the company and new investors should take a close look, Midas said in the Mail on Sunday. Midas tipped the company, which owns 265 buildings housing GP surgeries, in October 2008 and the shares have risen from 280p to 400p since then. PHP wants to increase its portfolio of properties from just over £1bn now to £1.5bn. The company has increased its dividend for each of the past 18 years and its shares have a 5% yield. It is an attractive income share with some growth prospects added.

Please note: Digital Look provides a round-up of news, tips and information that is impacting share prices and the market. Digital Look cannot take any responsibility for information provided by third parties. This is for your general information only and not intended to be relied upon by users in making an investment decision or any other decision. Please obtain a copy of the relevant publication and carry out your own research before considering acting on any of this information.